Article

B&L appoints senior vice president for R&D

Bausch & Lomb names Praveen Tyle, PhD, its senior vice president of research and development (R&D) and chief scientific officer.

Bausch & Lomb names Praveen Tyle, PhD, its senior vice president of research and development (R&D) and chief scientific officer.

Dr. Tyle joins Bausch & Lomb from Biovail Corp., where he served since 2003 as group vice president of pharmaceutical sciences and manufacturing. He also spent 4 years at Pharmacia Corp., where he was most recently vice president and global head of pharmaceutical sciences.

"Dr. Tyle brings to Bausch & Lomb a record of success in moving products from the laboratory to the market," said Ronald L. Zarrella, Bausch & Lomb chairman and chief executive officer, in a company statement. "Perhaps equally important is his extensive experience in drug development, an area of key strategic for our company. We're confident he'll provide strong scientific leadership as the company significantly increases its commitment to R&D."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.